肠梗阻术后重症线粒体脑肌病1例

Abstract
Figure/Table
References
Related Citation (5)

[1]	Ahmed S T, Craven L,Russell O M, et al. Diagnosis and treatment of mitochondrial myopathies[J]. Neurotherapeutics,2018,15(4):943-953.
[2]	Canto S J, Grau J M, Garrabou G. The impact of mitochondrial deficiencies in neuromuscular diseases[J]. Antioxidants (Basel),2020,9(10):457.
[3]	Niu F N, Meng H L, Chang L L. et al. Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: evidence from proton MR spectroscopy and muscle biopsy[J]. CNS Neurosci Ther,2017,23(8):686-697.
[4]	Hattab A W, Emrick L T, Hsu J W. et al. Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation[J]. Mol Genet Metab,2016,117(4):407-412.
[5]	Winanto, Khong Z J, Soh B S, et al. Organoid cultures of MELAS neural cells reveal hyperactive Notch signaling that impacts neurodevelopment[J]. Cell Death Dis,2020,11(3):182.
[6]	Delia G, Eleonora M, Francesca M, et al. Can intestinal pseudo-obstruction drive recurrent stroke-like episodes in late-onset melas syndrome? A case report and review of the literature[J]. Front Neurol,2019, 10: 38.
[7]	Bhatia K D, Krishnan P, Kortman H, et al. Acute cortical lesions in melas syndrome: anatomic distribution, symmetry, and evolution[J]. AJNR Am J Neuroradiol,2020,41(1):167-173.
[8]	Rodan L H, Poublanc J, Fisher J A. et al. L-arginine effects on cerebrovascular reactivity, perfusion and neurovascular coupling in MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) syndrome[J]. PLoS One,2020,15(9):e0238224.
[9]	Ganetzky R D, Falk M J. 8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease[J]. Mol Genet Metab,2018,123(3):301-308.
[10]	Hattab A W, Almannai, Scaglia F. Arginine and citrulline for the treatment of MELAS syndrome[J]. J Inborn Errors Metab Screen,2017,12:5123.
[11]	Francesco G, Vincenzo M, Costanza S, et al. Therapeutical management and drug safety in mitochondrial diseases-update 2020[J]. J Clin Med,2021,10(1): 10094.
[12]	虎磐,薛超,周飞虎, 等. 血乳酸水平与休克患者肠内营养耐受性的相关性[J]. 武警医学,2020,31(4):291-295.
[13]	Jung B, Martinez M, Claessens Y E,et al. Diagnosis and management of metabolic acidosis: guidelines from a French expert panel[J]. Ann Intensive Care,2019,9(1):92.